Detalhe da pesquisa
1.
Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia.
Hematol Oncol;
40(1): 57-62, 2022 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34653277
2.
Identification of a Maturation Plasma Cell Index through a Highly Sensitive Droplet Digital PCR Assay Gene Expression Signature Validation in Newly Diagnosed Multiple Myeloma Patients.
Int J Mol Sci;
23(20)2022 Oct 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36293315
3.
A real-world efficacy and safety analysis of combined carfilzomib, lenalidomide, and dexamethasone (KRd) in relapsed/refractory multiple myeloma.
Hematol Oncol;
39(1): 41-50, 2021 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33085797
4.
Disease-Specific Derangement of Circulating Endocannabinoids and N-Acylethanolamines in Myeloproliferative Neoplasms.
Int J Mol Sci;
21(9)2020 May 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32403407
5.
Novel agent-based salvage autologous stem cell transplantation for relapsed multiple myeloma.
Ann Hematol;
96(12): 2071-2078, 2017 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29063955
6.
HIF-1α inhibition blocks the cross talk between multiple myeloma plasma cells and tumor microenvironment.
Exp Cell Res;
328(2): 444-55, 2014 Nov 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25257607
7.
Bortezomib- and thalidomide-induced peripheral neuropathy in multiple myeloma: clinical and molecular analyses of a phase 3 study.
Am J Hematol;
89(12): 1085-91, 2014 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25159313
8.
Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with specific genomic, transcriptional and adverse clinical features.
Nat Commun;
15(1): 1551, 2024 Feb 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38378709
9.
Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients.
Cells;
13(8)2024 Apr 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38667272
10.
Treatment optimization for multiple myeloma: schedule-dependent synergistic cytotoxicity of pomalidomide and carfilzomib in in vitro and ex vivo models.
Haematologica;
103(12): e602-e606, 2018 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30026343
11.
Correlation between eight-gene expression profiling and response to therapy of newly diagnosed multiple myeloma patients treated with thalidomide-dexamethasone incorporated into double autologous transplantation.
Ann Hematol;
92(9): 1271-80, 2013 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23660628
12.
High levels of CRBN isoform lacking IMiDs binding domain predicts for a worse response to IMiDs-based upfront therapy in newly diagnosed myeloma patients.
Clin Exp Med;
23(8): 5227-5239, 2023 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37815734
13.
Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma.
Front Oncol;
13: 1208741, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37305577
14.
The ALLgorithMM: How to define the hemodilution of bone marrow samples in lymphoproliferative diseases.
Front Oncol;
12: 1001048, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36276072
15.
Next-Generation Sequencing for Clinical Management of Multiple Myeloma: Ready for Prime Time?
Front Oncol;
10: 189, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32181154
16.
Integrative analysis of the genomic and transcriptomic landscape of double-refractory multiple myeloma.
Blood Adv;
4(5): 830-844, 2020 03 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32126144
17.
Minimal Residual Disease Assessment Within the Bone Marrow of Multiple Myeloma: A Review of Caveats, Clinical Significance and Future Perspectives.
Front Oncol;
9: 699, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31482061
18.
Prognostic impact of serial measurements of serum-free light chain assay throughout the course of newly diagnosed multiple myeloma treated with bortezomib-based regimens.
Leuk Lymphoma;
57(9): 2058-64, 2016 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26763357
19.
The genetic and genomic background of multiple myeloma patients achieving complete response after induction therapy with bortezomib, thalidomide and dexamethasone (VTD).
Oncotarget;
7(9): 9666-79, 2016 Mar 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26575327
20.
Therapeutic targeting of hypoxia and hypoxia-inducible factor 1 alpha in multiple myeloma.
Transl Res;
165(6): 641-50, 2015 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25553605